Headline Details

U.S. FDA gives broader approval to GSK's Zejula for ovarian cancer

Published on: Wed, 29 Apr 2020 20:05:20 UTC
News Agency: Reuters
Description:
The U.S. Food and Drug Administration on Wednesday cleared expanded use of GlaxoSmithKline Plc's Zejula as a first option to keep advanced ovarian cancer at bay in women who have responded to chemotherapy.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
Iran vows 'crushing response to US bullying' after sanctions announcement BBC
Egypt tomb: Sarcophagi buried for 2,500 years unearthed in Saqqara BBC
Gore-Tex: Inventor of waterproof fabric Robert Gore dies aged 83 BBC
Thai monarchy reform protesters declare 'victory' after delivering their demands CNN
Torch-inspired Tokyo skyscraper to become Japan's tallest building CNN